Recent Updates
Recently added Catalysts
INFU Positive Sentiment Score: 70/100

InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem to Report First Quarter 202

Key Takeaway: InfuSystem Holdings, Inc. will report its first quarter 2023 financial results on May 4, 2023, prior to the market opening. An investor conference call is scheduled for the same day at 9:00 a.m. Eastern Time to discuss the results. The company, which specializes in outpatient health care services, continues to engage with stakeholders through this communication effort.

Market Sentiment Analysis

POSITIVE FACTORS

  • InfuSystem is set to report its first quarter 2023 financial results.
  • The company demonstrates proactive communication with an investor conference call.
  • InfuSystem has established a strong service model within its healthcare offerings.

Full Press Release Details

CONTACT Joe Dorame, Joe Diaz Robert Blum
Lytham Partners, LLC
InfuSystem to Report First Quarter 2023 Financial Results on May 4, 2023
Investor Conference Call to be held 9 00 a.m. Eastern Time
Rochester Hills, Michigan, April 27, 2023 - InfuSystem Holdings, Inc. (NYSE American INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue first quarter 2023 financial results on Thursday, May 4, 2023, before the market opens.
The Company will also conduct a conference call for all interested parties on Thursday, May 4, 2023 at 9 00 a.m. Eastern Time to discuss its financial results.
To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in the Investors section of the Company's website at https ir.infusystem.com . A replay of the call will be available by visiting https ir.infusystem.com for the next 90 days or by calling (877) 344-7529 or (412) 317-0088, confirmation code 9911637 through Thursday, May 11, 2023.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. (NYSE American INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The lead platform is Integrated Therapy Services ("ITS"), providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The ITS segment is comprised of Oncology, Pain Management, Wound Therapy and Lymphedema businesses. The second platform, Durable Medical Equipment Services ("DME Services"), supports the ITS platform and leverages strong service orientation to win incremental business from its direct payer clients. The DME Services segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.

Frequently Asked Questions

When will InfuSystem release Q1 2023 financial results?

InfuSystem will announce its Q1 2023 financial results on May 4, 2023.

What time is the investor conference call scheduled?

The investor conference call is set for 9:00 a.m. Eastern Time on May 4, 2023.

How can I listen to the conference call?

You can listen via a phone call or live webcast from InfuSystem's investor website.

What are InfuSystem's main service platforms?

InfuSystem operates through Integrated Therapy Services and Durable Medical Equipment Services.

Where is InfuSystem Holdings, Inc. headquartered?

InfuSystem Holdings, Inc. is headquartered in Rochester Hills, Michigan.

Last updated: Apr 27, 2023